<?xml version="1.0" encoding="UTF-8"?>
<p>Visual screening for the presence of symptoms was also part of the screening protocols [
 <xref rid="B6-ijerph-16-04638" ref-type="bibr">6</xref>,
 <xref rid="B7-ijerph-16-04638" ref-type="bibr">7</xref>,
 <xref rid="B8-ijerph-16-04638" ref-type="bibr">8</xref>,
 <xref rid="B9-ijerph-16-04638" ref-type="bibr">9</xref>,
 <xref rid="B10-ijerph-16-04638" ref-type="bibr">10</xref>,
 <xref rid="B11-ijerph-16-04638" ref-type="bibr">11</xref>,
 <xref rid="B16-ijerph-16-04638" ref-type="bibr">16</xref>,
 <xref rid="B20-ijerph-16-04638" ref-type="bibr">20</xref>,
 <xref rid="B21-ijerph-16-04638" ref-type="bibr">21</xref>,
 <xref rid="B22-ijerph-16-04638" ref-type="bibr">22</xref>,
 <xref rid="B23-ijerph-16-04638" ref-type="bibr">23</xref>,
 <xref rid="B26-ijerph-16-04638" ref-type="bibr">26</xref>,
 <xref rid="B27-ijerph-16-04638" ref-type="bibr">27</xref>,
 <xref rid="B33-ijerph-16-04638" ref-type="bibr">33</xref>,
 <xref rid="B34-ijerph-16-04638" ref-type="bibr">34</xref>,
 <xref rid="B35-ijerph-16-04638" ref-type="bibr">35</xref>,
 <xref rid="B37-ijerph-16-04638" ref-type="bibr">37</xref>,
 <xref rid="B38-ijerph-16-04638" ref-type="bibr">38</xref>,
 <xref rid="B40-ijerph-16-04638" ref-type="bibr">40</xref>] and/or rapid diagnostic tests [
 <xref rid="B7-ijerph-16-04638" ref-type="bibr">7</xref>,
 <xref rid="B10-ijerph-16-04638" ref-type="bibr">10</xref>,
 <xref rid="B24-ijerph-16-04638" ref-type="bibr">24</xref>,
 <xref rid="B26-ijerph-16-04638" ref-type="bibr">26</xref>,
 <xref rid="B39-ijerph-16-04638" ref-type="bibr">39</xref>] to identify suspected cases. Finally, medical and laboratory assessments were conducted for suspected travelers [
 <xref rid="B6-ijerph-16-04638" ref-type="bibr">6</xref>,
 <xref rid="B7-ijerph-16-04638" ref-type="bibr">7</xref>,
 <xref rid="B8-ijerph-16-04638" ref-type="bibr">8</xref>,
 <xref rid="B9-ijerph-16-04638" ref-type="bibr">9</xref>,
 <xref rid="B10-ijerph-16-04638" ref-type="bibr">10</xref>,
 <xref rid="B11-ijerph-16-04638" ref-type="bibr">11</xref>,
 <xref rid="B15-ijerph-16-04638" ref-type="bibr">15</xref>,
 <xref rid="B16-ijerph-16-04638" ref-type="bibr">16</xref>,
 <xref rid="B20-ijerph-16-04638" ref-type="bibr">20</xref>,
 <xref rid="B21-ijerph-16-04638" ref-type="bibr">21</xref>,
 <xref rid="B22-ijerph-16-04638" ref-type="bibr">22</xref>,
 <xref rid="B23-ijerph-16-04638" ref-type="bibr">23</xref>,
 <xref rid="B24-ijerph-16-04638" ref-type="bibr">24</xref>,
 <xref rid="B26-ijerph-16-04638" ref-type="bibr">26</xref>,
 <xref rid="B27-ijerph-16-04638" ref-type="bibr">27</xref>,
 <xref rid="B29-ijerph-16-04638" ref-type="bibr">29</xref>,
 <xref rid="B31-ijerph-16-04638" ref-type="bibr">31</xref>,
 <xref rid="B32-ijerph-16-04638" ref-type="bibr">32</xref>,
 <xref rid="B33-ijerph-16-04638" ref-type="bibr">33</xref>,
 <xref rid="B34-ijerph-16-04638" ref-type="bibr">34</xref>,
 <xref rid="B35-ijerph-16-04638" ref-type="bibr">35</xref>,
 <xref rid="B36-ijerph-16-04638" ref-type="bibr">36</xref>,
 <xref rid="B38-ijerph-16-04638" ref-type="bibr">38</xref>,
 <xref rid="B39-ijerph-16-04638" ref-type="bibr">39</xref>,
 <xref rid="B40-ijerph-16-04638" ref-type="bibr">40</xref>]. Methods for entry and exit screening, accompanying measures, response measures and laboratory diagnosis are summarized in 
 <xref rid="ijerph-16-04638-t006" ref-type="table">Table 6</xref>.
</p>
